Further, these data imply that the progression of CLN1 may be mediated by the palmitoylation of Fyn kinase, which is also being targeted for the treatment of Alzheimer’s disease (Kaufman et al., 2015; Nygaard et al., 2015). Here, PPT1 is linked to early-onset autosomal dominant Alzheimer disease.